Page last updated: 2024-10-22

amitriptyline and Experimental Neoplasms

amitriptyline has been researched along with Experimental Neoplasms in 3 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Richelson, E1
Brandes, LJ1
Arron, RJ1
Bogdanovic, RP1
Tong, J1
Zaborniak, CL1
Hogg, GR1
Warrington, RC1
Fang, W1
LaBella, FS1
Marx, J1

Other Studies

3 other studies available for amitriptyline and Experimental Neoplasms

ArticleYear
Tricyclic antidepressants and histamine H1 receptors.
    Mayo Clinic proceedings, 1979, Volume: 54, Issue:10

    Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Atropine; Benztropine; Cells, Cultured; Cl

1979
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.
    Cancer research, 1992, Jul-01, Volume: 52, Issue:13

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Amitriptyline; Animals; Antidepressive Agents; DNA; Fluoxetine; Ly

1992
Do antidepressants promote tumors?
    Science (New York, N.Y.), 1992, Jul-03, Volume: 257, Issue:5066

    Topics: Amitriptyline; Animals; Breast Neoplasms; Carcinogens; Female; Fluoxetine; Humans; Mice; Neoplasms,

1992